Recall injection-site reactions to etanercept in a patient with psoriasis

Clinical and Experimental Dermatology

Volumn 34, Issue 3, 2009, Pages 414-415

  Papadavid, E ^a   Makris, M ^a   Dalamaga, M ^a   Kalogeromitros, D ^a   Stavrianeas, N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ETANERCEPT; STEROID;

ABDOMEN; ADULT; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HELPER CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INJECTION SITE; INJECTION SITE REACTION; INTRACUTANEOUS TEST; LETTER; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62449210414     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02945.x     Document Type: Letter

References (5)

1. Gonzalez-Lopez MA, Martinez-Taboada VM, Gonzalez-Vela MC et al. Recall injection site reactions associated with etanercept therapy: report of two new cases with immunohistochemical analysis. Clin Exp Dermatol 2007 32 : 672 4.
2. Moreland LW, Schiff MH, Baumgartner SW et al. Etanercept therapy in rheumatoid arthritis: a randomized controlled trial. Ann Intern Med 1999 130 : 478 86.
3. Zeltser R, Valle L, Tanck C et al. Clinical, histological and immunophenotypic characteristics of injection site reactions associated with etanercept. Arch Dermatol 2001 137 : 893 9.
4. Winfield H, Lain E, Horn T, Hoskyn J. Eosinophilic cellulitis-like reaction to subcutaneous etanercept injection. Arch Dermatol 2006 142 : 218 20.
5. Benucci M, Manfredy M, Demoly P, Campi P. Injection site reactions to TNF-α blocking agents with positive skin tests. Allergy 2008 63 : 138 9.